Population
Human platelets (normal and thrombasthenic)
Comparison
Inhibition of integrin αIIbβ3 (using RGDS ligand… vs Normal thrombin-induced platelet aggregation…
Design
Preclinical
Authors
Loading...
Does not inform antiplatelet strategies; leaves open whether αIIbβ3-ERK2 regulation affects human thrombosis.
This study provides the first evidence that integrin engagement (αIIbβ3 during platelet aggregation) down-regulates the MAP kinase pathway (ERK2 activation).
Nadal et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: